Bivin & Associates’s Cigna CI Stock Holding History

Bivin & Associates’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-18	Closed	-$4K	–	360
2021 Q4	$4K	Buy	+18	New	+$3.83K	﹤0.01%	221

Other funds holding CI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bivin & Associates's CI Position: Q1 2022 in Review

Bivin & Associates sold out of Cigna (CI) in Q1 2022, closing a stake of 18 shares — an estimated $4K sold.

Bivin & Associates first reported a position in CI in Q4 2021 and held it in 1 quarter. The position peaked at $4K in Q4 2021. 1,376 funds tracked by Wall St. Rank hold CI as of Q1 2022.

Bivin & Associates reported no remaining Cigna position as of Q1 2022 after selling out during the quarter.
Bivin & Associates sold 18 Cigna shares in Q1 2022, an estimated $4K.
Bivin & Associates first reported a position in Cigna in Q4 2021 and held it in 1 quarter.
Bivin & Associates's Cigna position peaked at $4K in Q4 2021.
1,376 funds tracked by Wall St. Rank held Cigna as of Q1 2022.

Based on Bivin & Associates's 13F filing for Q1 2022, filed 6 May 2022.